Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus

Published:2019-12-03 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Madsen Kasper S¹,Chi Yuan²,Metzendorf Maria-Inti³,Richter Bernd³,Hemmingsen Bianca³

Affiliation:

1. University of Copenhagen; Faculty of Health and Medical Sciences; Blegdamsvej 3B Copenhagen N Denmark 2200

2. University Hospital Zurich and University of Zurich; Institute for Complementary and Integrative Medicine; Sonneggstrasse 6 Zurich Beijing Switzerland 8006

3. Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf; Cochrane Metabolic and Endocrine Disorders Group; Moorenstr. 5 Düsseldorf Germany 40225

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008558.pub2/epdf/full

Reference262 articles.

1. Alfawaz HA Wani K Alnaami AM Al-Saleh Y Aljohani NJ Al-Attas OS Effects of different dietary and lifestyle modification therapies on metabolic syndrome in prediabetic Arab patients: a 12-month longitudinal study Nutrients 2018 pii: E383

2. Charles MA Morange P Eschwege E Andre P Vague P Juhan-Vague I Effect of weight change and metformin on fibrinolysis and the von willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the prevention of the risk of obesity Diabetes Care 1998

3. BIGPRO (biguanides and the prevention of the risk of obesity): study design. A randomized trial of metformin versus placebo in the correction of the metabolic abnormalities associated with insulin resistance;Fontbonne;Diabetes & Metabolism,1991

4. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial;Fontbonne;Diabetes & Metabolism,2009

5. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution;Fontbonne;Diabetes Care,1996

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Type 2 Diabetes Mellitus: Synopsis of the Department of Veterans Affairs and Department of Defense Clinical Practice Guideline;Mayo Clinic Proceedings;2024-08

2. Comprehensive Evidence-Based Health Maintenance;The American Journal of Medicine;2024-08

3. Metformin improves cognitive dysfunction through SIRT1/NLRP3 pathway–mediated neuroinflammation in db/db mice;Journal of Molecular Medicine;2024-07-02

4. Safety of Contrast Agents Administration in Patients with Type 2 Diabetes Mellitus During Metformin Intake;Journal of radiology and nuclear medicine;2024-05-26

5. MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program;International Journal of Molecular Sciences;2024-05-23